Where AI Delivers Real Value in Pharma Today with Emily Lewis

Here’s what keeps pharma leaders awake at night: 70% to 80% of ChatGPT usage is healthcare-related; however, most pharmaceutical organizations still treat AI as a future consideration rather than an immediate competitive necessity. In this episode of Pharma Sessions, host Jonathan Kaskey is joined by Emily Lewis, Artificial Intelligence and Innovation Lead for Digital Care Transformation at UCB, to explore why LLMs alone won’t move medicine forward, how to build cross-functional AI literacy across your organization, and the regulatory workflows where AI will deliver impact fastest. Disclaimer: Pharma Sessions is for informational purposes only and does not constitute medical, legal, or financial advice. Guest opinions are their own and do not reflect the views of the host or sponsors. Use of any information provided is at the listener’s own risk and does not imply endorsement of specific products or strategies.